Carbocycles Related to Oseltamivir as Influenza Virus Group-1-Specific Neuraminidase Inhibitors. Binding to N1 Enzymes in the Context of Virus-like Particles
We report here the exploitation of the 150-cavity in the active sites of group-1 neuraminidases for the design of new triazole-containing carbocycles related to oseltamivir. Inhibition studies with virus-like particles (VLPs) containing the influenza virus neuraminidase-1 (N1) activity indicate that...
Gespeichert in:
Veröffentlicht in: | Journal of medicinal chemistry 2010-10, Vol.53 (20), p.7377-7391 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 7391 |
---|---|
container_issue | 20 |
container_start_page | 7377 |
container_title | Journal of medicinal chemistry |
container_volume | 53 |
creator | Mohan, Sankar McAtamney, Sarah Haselhorst, Thomas von Itzstein, Mark Pinto, Brian Mario |
description | We report here the exploitation of the 150-cavity in the active sites of group-1 neuraminidases for the design of new triazole-containing carbocycles related to oseltamivir. Inhibition studies with virus-like particles (VLPs) containing the influenza virus neuraminidase-1 (N1) activity indicate that several candidates are inhibitors, with K i values in the 10−5−10−8 M range. In contrast, a known candidate that preserves the free amino group and a new candidate containing a guanidine function are better inhibitors, with K i values of 1.5 × 10−9 and 4.6 × 10−10 M, respectively. The most active inhibitor of the N1 enzyme in the triazole series was selective for the N1 class and showed significantly less inhibition (K i = 2.6 μM vs 0.07 μM) of the free influenza virus neuraminidase-2 (N2). In addition, saturation transfer difference (STD) NMR spectroscopic studies with this compound and the VLPs show that the entire molecule forms contacts with residues in the active site. These data taken together support our proposed binding mode in which the active site and the adjoining 150-cavity are both occupied. |
doi_str_mv | 10.1021/jm100822f |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_759874583</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>759874583</sourcerecordid><originalsourceid>FETCH-LOGICAL-a314t-df0b8c43f6b578fd2cf9461f8b6a52c18dd4445c7fa0ecd8ab95fce09a2a51a13</originalsourceid><addsrcrecordid>eNpt0UFvFCEUwHFiNHZbPfgFDBfT9DAVGNhhjrqptUnTGlu9Tt7Aw7LOwApM4_a7-F2dzdaePHH55f-AR8gbzk45E_z9euSMaSHcM7LgSrBKaiafkwVjQlRiKeoDcpjzmjFWc1G_JAeC6aZuWrUgf1aQ-mi2ZsBMv-IABS0tkV5nHAqM_t4nCpleBDdMGB6AfvdpyvQ8xWlT8epmg8Y7b-gVTmnmwVvIOPM73_sSUz6lH32wPvzYRa84PQsP23Ee5QMtd0hXMRT8XWh0-3A1-J9Iv0AqfnejV-SFgyHj68fziHz7dHa7-lxdXp9frD5cVlBzWSrrWK-NrN2yV412VhjXyiV3ul-CEoZra6WUyjQOGBqroW-VM8haEKA48PqIHO-7mxR_TZhLN_pscBggYJxy16hWN1LpepYne2lSzDmh6zbJj5C2HWfdbhnd0zJm-_axOvUj2if57_dn8G4PwORuHacU5kf-J_QXWTSTXA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>759874583</pqid></control><display><type>article</type><title>Carbocycles Related to Oseltamivir as Influenza Virus Group-1-Specific Neuraminidase Inhibitors. Binding to N1 Enzymes in the Context of Virus-like Particles</title><source>MEDLINE</source><source>ACS Publications</source><creator>Mohan, Sankar ; McAtamney, Sarah ; Haselhorst, Thomas ; von Itzstein, Mark ; Pinto, Brian Mario</creator><creatorcontrib>Mohan, Sankar ; McAtamney, Sarah ; Haselhorst, Thomas ; von Itzstein, Mark ; Pinto, Brian Mario</creatorcontrib><description>We report here the exploitation of the 150-cavity in the active sites of group-1 neuraminidases for the design of new triazole-containing carbocycles related to oseltamivir. Inhibition studies with virus-like particles (VLPs) containing the influenza virus neuraminidase-1 (N1) activity indicate that several candidates are inhibitors, with K i values in the 10−5−10−8 M range. In contrast, a known candidate that preserves the free amino group and a new candidate containing a guanidine function are better inhibitors, with K i values of 1.5 × 10−9 and 4.6 × 10−10 M, respectively. The most active inhibitor of the N1 enzyme in the triazole series was selective for the N1 class and showed significantly less inhibition (K i = 2.6 μM vs 0.07 μM) of the free influenza virus neuraminidase-2 (N2). In addition, saturation transfer difference (STD) NMR spectroscopic studies with this compound and the VLPs show that the entire molecule forms contacts with residues in the active site. These data taken together support our proposed binding mode in which the active site and the adjoining 150-cavity are both occupied.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm100822f</identifier><identifier>PMID: 20873795</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Antiviral Agents - chemical synthesis ; Antiviral Agents - chemistry ; Catalytic Domain ; Influenza A virus - enzymology ; Magnetic Resonance Spectroscopy ; Models, Molecular ; Neuraminidase - antagonists & inhibitors ; Neuraminidase - chemistry ; Oseltamivir - analogs & derivatives ; Oseltamivir - chemical synthesis ; Oseltamivir - chemistry ; Protein Binding ; Stereoisomerism ; Triazoles - chemical synthesis ; Triazoles - chemistry ; Virion - drug effects ; Virion - enzymology</subject><ispartof>Journal of medicinal chemistry, 2010-10, Vol.53 (20), p.7377-7391</ispartof><rights>Copyright © 2010 American Chemical Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a314t-df0b8c43f6b578fd2cf9461f8b6a52c18dd4445c7fa0ecd8ab95fce09a2a51a13</citedby><cites>FETCH-LOGICAL-a314t-df0b8c43f6b578fd2cf9461f8b6a52c18dd4445c7fa0ecd8ab95fce09a2a51a13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/jm100822f$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/jm100822f$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,780,784,2764,27075,27923,27924,56737,56787</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20873795$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mohan, Sankar</creatorcontrib><creatorcontrib>McAtamney, Sarah</creatorcontrib><creatorcontrib>Haselhorst, Thomas</creatorcontrib><creatorcontrib>von Itzstein, Mark</creatorcontrib><creatorcontrib>Pinto, Brian Mario</creatorcontrib><title>Carbocycles Related to Oseltamivir as Influenza Virus Group-1-Specific Neuraminidase Inhibitors. Binding to N1 Enzymes in the Context of Virus-like Particles</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>We report here the exploitation of the 150-cavity in the active sites of group-1 neuraminidases for the design of new triazole-containing carbocycles related to oseltamivir. Inhibition studies with virus-like particles (VLPs) containing the influenza virus neuraminidase-1 (N1) activity indicate that several candidates are inhibitors, with K i values in the 10−5−10−8 M range. In contrast, a known candidate that preserves the free amino group and a new candidate containing a guanidine function are better inhibitors, with K i values of 1.5 × 10−9 and 4.6 × 10−10 M, respectively. The most active inhibitor of the N1 enzyme in the triazole series was selective for the N1 class and showed significantly less inhibition (K i = 2.6 μM vs 0.07 μM) of the free influenza virus neuraminidase-2 (N2). In addition, saturation transfer difference (STD) NMR spectroscopic studies with this compound and the VLPs show that the entire molecule forms contacts with residues in the active site. These data taken together support our proposed binding mode in which the active site and the adjoining 150-cavity are both occupied.</description><subject>Antiviral Agents - chemical synthesis</subject><subject>Antiviral Agents - chemistry</subject><subject>Catalytic Domain</subject><subject>Influenza A virus - enzymology</subject><subject>Magnetic Resonance Spectroscopy</subject><subject>Models, Molecular</subject><subject>Neuraminidase - antagonists & inhibitors</subject><subject>Neuraminidase - chemistry</subject><subject>Oseltamivir - analogs & derivatives</subject><subject>Oseltamivir - chemical synthesis</subject><subject>Oseltamivir - chemistry</subject><subject>Protein Binding</subject><subject>Stereoisomerism</subject><subject>Triazoles - chemical synthesis</subject><subject>Triazoles - chemistry</subject><subject>Virion - drug effects</subject><subject>Virion - enzymology</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpt0UFvFCEUwHFiNHZbPfgFDBfT9DAVGNhhjrqptUnTGlu9Tt7Aw7LOwApM4_a7-F2dzdaePHH55f-AR8gbzk45E_z9euSMaSHcM7LgSrBKaiafkwVjQlRiKeoDcpjzmjFWc1G_JAeC6aZuWrUgf1aQ-mi2ZsBMv-IABS0tkV5nHAqM_t4nCpleBDdMGB6AfvdpyvQ8xWlT8epmg8Y7b-gVTmnmwVvIOPM73_sSUz6lH32wPvzYRa84PQsP23Ee5QMtd0hXMRT8XWh0-3A1-J9Iv0AqfnejV-SFgyHj68fziHz7dHa7-lxdXp9frD5cVlBzWSrrWK-NrN2yV412VhjXyiV3ul-CEoZra6WUyjQOGBqroW-VM8haEKA48PqIHO-7mxR_TZhLN_pscBggYJxy16hWN1LpepYne2lSzDmh6zbJj5C2HWfdbhnd0zJm-_axOvUj2if57_dn8G4PwORuHacU5kf-J_QXWTSTXA</recordid><startdate>20101028</startdate><enddate>20101028</enddate><creator>Mohan, Sankar</creator><creator>McAtamney, Sarah</creator><creator>Haselhorst, Thomas</creator><creator>von Itzstein, Mark</creator><creator>Pinto, Brian Mario</creator><general>American Chemical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20101028</creationdate><title>Carbocycles Related to Oseltamivir as Influenza Virus Group-1-Specific Neuraminidase Inhibitors. Binding to N1 Enzymes in the Context of Virus-like Particles</title><author>Mohan, Sankar ; McAtamney, Sarah ; Haselhorst, Thomas ; von Itzstein, Mark ; Pinto, Brian Mario</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a314t-df0b8c43f6b578fd2cf9461f8b6a52c18dd4445c7fa0ecd8ab95fce09a2a51a13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Antiviral Agents - chemical synthesis</topic><topic>Antiviral Agents - chemistry</topic><topic>Catalytic Domain</topic><topic>Influenza A virus - enzymology</topic><topic>Magnetic Resonance Spectroscopy</topic><topic>Models, Molecular</topic><topic>Neuraminidase - antagonists & inhibitors</topic><topic>Neuraminidase - chemistry</topic><topic>Oseltamivir - analogs & derivatives</topic><topic>Oseltamivir - chemical synthesis</topic><topic>Oseltamivir - chemistry</topic><topic>Protein Binding</topic><topic>Stereoisomerism</topic><topic>Triazoles - chemical synthesis</topic><topic>Triazoles - chemistry</topic><topic>Virion - drug effects</topic><topic>Virion - enzymology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mohan, Sankar</creatorcontrib><creatorcontrib>McAtamney, Sarah</creatorcontrib><creatorcontrib>Haselhorst, Thomas</creatorcontrib><creatorcontrib>von Itzstein, Mark</creatorcontrib><creatorcontrib>Pinto, Brian Mario</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mohan, Sankar</au><au>McAtamney, Sarah</au><au>Haselhorst, Thomas</au><au>von Itzstein, Mark</au><au>Pinto, Brian Mario</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Carbocycles Related to Oseltamivir as Influenza Virus Group-1-Specific Neuraminidase Inhibitors. Binding to N1 Enzymes in the Context of Virus-like Particles</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2010-10-28</date><risdate>2010</risdate><volume>53</volume><issue>20</issue><spage>7377</spage><epage>7391</epage><pages>7377-7391</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><abstract>We report here the exploitation of the 150-cavity in the active sites of group-1 neuraminidases for the design of new triazole-containing carbocycles related to oseltamivir. Inhibition studies with virus-like particles (VLPs) containing the influenza virus neuraminidase-1 (N1) activity indicate that several candidates are inhibitors, with K i values in the 10−5−10−8 M range. In contrast, a known candidate that preserves the free amino group and a new candidate containing a guanidine function are better inhibitors, with K i values of 1.5 × 10−9 and 4.6 × 10−10 M, respectively. The most active inhibitor of the N1 enzyme in the triazole series was selective for the N1 class and showed significantly less inhibition (K i = 2.6 μM vs 0.07 μM) of the free influenza virus neuraminidase-2 (N2). In addition, saturation transfer difference (STD) NMR spectroscopic studies with this compound and the VLPs show that the entire molecule forms contacts with residues in the active site. These data taken together support our proposed binding mode in which the active site and the adjoining 150-cavity are both occupied.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>20873795</pmid><doi>10.1021/jm100822f</doi><tpages>15</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-2623 |
ispartof | Journal of medicinal chemistry, 2010-10, Vol.53 (20), p.7377-7391 |
issn | 0022-2623 1520-4804 |
language | eng |
recordid | cdi_proquest_miscellaneous_759874583 |
source | MEDLINE; ACS Publications |
subjects | Antiviral Agents - chemical synthesis Antiviral Agents - chemistry Catalytic Domain Influenza A virus - enzymology Magnetic Resonance Spectroscopy Models, Molecular Neuraminidase - antagonists & inhibitors Neuraminidase - chemistry Oseltamivir - analogs & derivatives Oseltamivir - chemical synthesis Oseltamivir - chemistry Protein Binding Stereoisomerism Triazoles - chemical synthesis Triazoles - chemistry Virion - drug effects Virion - enzymology |
title | Carbocycles Related to Oseltamivir as Influenza Virus Group-1-Specific Neuraminidase Inhibitors. Binding to N1 Enzymes in the Context of Virus-like Particles |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T11%3A02%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Carbocycles%20Related%20to%20Oseltamivir%20as%20Influenza%20Virus%20Group-1-Specific%20Neuraminidase%20Inhibitors.%20Binding%20to%20N1%20Enzymes%20in%20the%20Context%20of%20Virus-like%20Particles&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Mohan,%20Sankar&rft.date=2010-10-28&rft.volume=53&rft.issue=20&rft.spage=7377&rft.epage=7391&rft.pages=7377-7391&rft.issn=0022-2623&rft.eissn=1520-4804&rft_id=info:doi/10.1021/jm100822f&rft_dat=%3Cproquest_cross%3E759874583%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=759874583&rft_id=info:pmid/20873795&rfr_iscdi=true |